Fox Chase Cancer Center is a member of the National Comprehensive Cancer Network® (NCCN), a not-for-profit alliance of 30 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. More than 160,000 new patients receive cancer care at NCCN Member Institutions over the course of any year.
The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. As a member of the NCCN, Fox Chase offers its patients superior treatments, the latest technologies and broader access to clinical trials through our multidisciplinary team of physicians, health care professionals and researchers.
A distinction for Fox Chase in the Philadelphia area is that many Fox Chase physicians and researchers are on advisory boards at the NCCN, writing the guidelines used here and at other cancer treatment centers nationwide.
NCCN Guidelines for Patients®: an educational tool for patients and oncology professionals
The NCCN Guidelines for Patients®, translations of the NCCN Guidelines, are meant to help patients with cancer speak with their treating oncologist about their best treatment options.
Read more at NCCN.org
